Page 183 - Read Online

Cui et al. Diagnosis and treatment of meningeal carcinomatosis

5. Eberth CJ. Zur Entwickelung des Epithelioms (Cholesteatoms) der Pia MR, Weinberg J, Cristofanilli M, Yung WK, Liu TJ. Biomarkers
und der Lunge. Arch Pathol Anat Physiol Klin Med 1870;49:51-63. of disease: cerebrospinal fluid vascular endothelial growth factor
6. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS. Breast (VEGF) and stromal cell derived factor (SDF)-1 levels in patients
cancer metastasis to the central nervous system. Am J Pathol with neoplastic meningitis (NM) due to breast cancer, lung cancer and
2005;167:913-20. melanoma. J Neurooncol 2009;94:229-34.
7. Aragon-Ching JB, Zujewski JA. CNS metastasis: an old problem in a 27. Orphanos G, Ioannidis G, Michael M, Kitrou G. Prostate-specific
new guise. Clin Cancer Res 2007;13:1644-7. antigen in the cerebrospinal fluid: a marker of local disease. Med
8. Chamberlain MC. Neoplastic meningitis. Curr Neurol Neurosci Rep Oncol 2009;26:143-6.
2008;8:249-58. 28. Chamberlain MC. Cytologically negative carcinomatous meningitis:
9. Pace A, Fabi A. Chemotherapy in neoplastic meningitis. Crit Rev usefulness of CSF biochemical markers. Neurology 1998;50:1173-5.
Oncol Hematol 2006;60:194-200. 29. Sasaki S, Yoshioka Y, Ko R, Katsura Y, Namba Y, Shukuya T, Kido
10. Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin K, Iwakami S, Tominaga S, Takahashi K. Diagnostic significance
2003;21:25-66. of cerebrospinal fluid EGFR mutation analysis for leptomeningeal
11. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis metastasis in non-small-cell lung cancer patients harboring an active
LM. Leptomeningeal metastases in the MRI era. Neurology EGFR mutation following gefitinib therapy failure. Respir Investig
2010;74:1449-54. 2016;54:14-9.
12. Beauchesne P. Intrathecal chemotherapy for treatment of 30. Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A,
leptomeningeal dissemination of metastatic tumours. Lancet Oncol Lin X, Fleisher M, Grommes C, Panageas KS, Meng F, Selcuklu SD,
2010;11:871-9. Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M, DeAngelis
13. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, LM, Viale A, Mellinghoff IK, Berger MF. Evaluating cancer of
Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert the central nervous system through next-generation sequencing of
MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael cerebrospinal fluid. J Clin Oncol 2016;34:2404-15.
M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, 31. Dietemann JL, Correia Bernardo R, Bogorin A, Abu Eid M, Koob M,
Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Vrionis FD, Nogueira T, Vargas MI, Fakhoury W, Zollner G. Normal and abnormal
Wen PY. Central nervous system cancers. J Natl Compr Canc Netw meningeal enhancement: MRI features. J Radiol 2005;86:1659-83.
2011;9:352-400. 32. Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu
14. de Azevedo CR, Cruz MR, Chinen LT, Peres SV, Peterlevitz MA, PH, Laurence V, Livartowski A, Mignot L, Dieras V. Survival of
de Azevedo Pereira AE, Fanelli MF, Gimenes DL. Meningeal breast cancer patients with meningeal carcinomatosis. Ann Oncol
carcinomatosis in breast cancer: prognostic factors and outcome. J 2010;21:2183-7.
Neurooncol 2011;104:565-72. 33. Chamberlain MC, Johnston SK. Neoplastic meningitis: survival as a
15. Chamberlain MC. Neoplastic meningitis. J Clin Oncol function of cerebrospinal fluid cytology. Cancer 2009;115:1941-6.
2005;23:3605-13. 34. Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez
16. Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic HR, Kris MG, Chan TA, DeAngelis LM, Omuro AM. Leptomeningeal
tools for neoplastic meningitis: detecting disease, identifying metastasis from non-small cell lung cancer: survival and the impact of
patient risk, and determining benefit of treatment. Semin Oncol whole brain radiotherapy. J Thorac Oncol 2012;7:382-5.
2009;36:S35-45. 35. Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM, Chung JH,
17. Jaeckle KA. Neoplastic meningitis from systemic malignancies: Kim JS, Lee JS. Clinical outcomes of leptomeningeal metastasis in
diagnosis, prognosis and treatment. Semin Oncol 2006;33:312-23. patients with non-small cell lung cancer in the modern chemotherapy
18. Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol era. Lung Cancer 2012;76:387-92.
2010;22:627-35. 36. Rudnicka H, Niwinska A, Murawska M. Breast cancer leptomeningeal
19. Guan H, Wang C, Guo Y, Chen L, Ren H, Zhao H. Specific findings in metastasis -- the role of multimodality treatment. J Neurooncol
cerebrospional fluid cytology. Chin J Neurol 2004;37:65-7. 2007;84:57-62.
20. Chamberlain MC. Neoplastic meningitis. Oncologist 2008;13:967-77. 37. Clatot F, Philippin-Lauridant G, Ouvrier MJ, Nakry T, Laberge-Le-
21. He J, Chen Q, Liu K, Wang L, Ynag X, Zou Y. Early diagnosis of Couteulx S, Guillemet C, Veyret C, Blot E. Clinical improvement and
patients with meningeal carcinomatosis with earcino-embryonic survival in breast cancer leptomeningeal metastasis correlate with
antigen hnmunocytochemical stain examination and laser scanning the cytologic response to intrathecal chemotherapy. J Neurooncol
confocal microscope. Chin J Neurol 2009;42:412-6. 2009;95:421-6.
22. Glantz MJ, Cole BF, Recht L, Akerley W, Mills P, Saris S, Hochberg 38. Mittl RL Jr, Yousem DM. Frequency of unexplained meningeal
F, Calabresi P, Egorin MJ. High-dose intravenous methotrexate for enhancement in the brain after lumbar puncture. AJNR Am J
patients with nonleukemic leptomeningeal cancer: is intrathecal Neuroradiol 1994;15:633-8.
chemotherapy necessary? J Clin Oncol 1998;16:1561-7. 39. Chamberlain MC. Radioisotope CSF flow studies in leptomeningeal
23. Wasserstrom WR, Schwartz MK, Fleisher M, Posner JB. Cerebrospinal metastases. J Neurooncol 1998;38:135-40.
fluid biochemical markers in central nervous system tumors: a review. 40. Glantz MJ, Hall WA, Cole BF, Chozick BS, Shannon CM, Wahlberg
Ann Clin Lab Sci 1981;11:239-51. L, Akerley W, Marin L, Choy H. Diagnosis, management, and survival
24. Stockhammer G, Poewe W, Burgstaller S, Deisenhammer F, Muigg A, of patients with leptomeningeal cancer based on cerebrospinal fluid-
Kiechl S, Schmutzhard E, Maier H, Felber S, Schumacher P, Gunsilius flow status. Cancer 1995;75:2919-31.
E, Gastl G. Vascular endothelial growth factor in CSF: a biological 41. Chamberlain MC. Comparative spine imaging in leptomeningeal
marker for carcinomatous meningitis. Neurology 2000;54:1670-6. metastases. J Neurooncol 1995;23:233-8.
25. Gauchez AS, Pez E, Boutonnat J, Bourre JC, Pelletier L, Payan R, 42. Chamberlain MC, Kormanik PA. Prognostic significance of
Mousseau M. Early detection of leptomeningeal metastasis in patients 111indium-DTPA CSF flow studies in leptomeningeal metastases.
with metastatic breast carcinoma: validation of CA 15-3 measurement Neurology 1996;46:1674-7.
in cerebrospinal fluid. Ann Biol Clin (Paris) 2007;65:653-8. 43. Mason WP, Yeh SD, DeAngelis LM. 111Indium-diethylenetriamine
26. Groves MD, Hess KR, Puduvalli VK, Colman H, Conrad CA, Gilbert pentaacetic acid cerebrospinal fluid flow studies predict distribution of
Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ September 18, 2017 175